Koers Protech Home Medical Corp Toronto S.E.
Aandelen
PHM
CA70324G1063
Gezondheidszorgvoorzieningen & -diensten
Omzet 2024 * | 357 mln. 260 mln. 243 mln. | Omzet 2025 * | 384 mln. 279 mln. 261 mln. | Marktkapitalisatie | 190 mln. 138 mln. 129 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -3 mln. -2,18 mln. -2,04 mln. | Nettowinst (verlies) 2025 * | 4 mln. 2,91 mln. 2,72 mln. | EV/omzet 2024 * | 0,53 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 0,49 x |
K/w-verhouding 2024 * |
-52,8
x | K/w-verhouding 2025 * |
31
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 96,08% |
Recentste transcriptie over Protech Home Medical Corp
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gregory Crawford
CEO | Chief Executive Officer | - | 19-04-16 |
Hardik Mehta
DFI | Director of Finance/CFO | - | 15-02-18 |
Mark Miles
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-10 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gregory Crawford
CEO | Chief Executive Officer | - | 19-04-16 |
Mark Greenberg
BRD | Director/Board Member | - | 21-12-17 |
Kevin Carter
BRD | Director/Board Member | - | 07-12-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+24,67% | 88,39 mld. | |
-23,73% | 75,6 mld. | |
+3,24% | 26,87 mld. | |
-12,06% | 16,85 mld. | |
-0,02% | 15,31 mld. | |
+75,93% | 13,53 mld. | |
+82,63% | 13,48 mld. | |
-24,56% | 13,01 mld. | |
+23,23% | 12,57 mld. |